KFF Health News' 'What the Health?': A Year Without Roe
It’s been a year since the Supreme Court overturned Roe v. Wade and, with it, the nationwide right to abortion. The decision in Dobbs v. Jackson Women’s Health Organization set off widespread uncertainty in government and the courts about the legality or illegality of the procedure. But the decision has had other consequences too, including affecting where health professionals choose to locate. In this special episode of KFF Health News’ “What the Health?” Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF’s Alina Salganicoff about the organization’s research and other work on women’s health policy over the past year.
Malpractice Lawsuits Over Denied Abortion Care May Be on the Horizon
Physicians and attorneys say it’s a question of when — not if — a pregnant person dies from lack of care in a state with an abortion ban, potentially setting the stage for a malpractice lawsuit that could pressure providers to reconsider delaying or denying care.
KFF Health News' 'What the Health?': Slow Your Disenroll
More than a million Americans have lost Medicaid coverage since pandemic protections ended. The Biden administration is asking states to slow disenrollment, but that does not mean states must listen. Meanwhile, a Supreme Court decision gives Medicaid beneficiaries the right to sue over their care, and a new deal preserves coverage of preventive services nationwide as a Texas court case continues. Rachel Cohrs of Stat, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KFF Health News’ Mary Agnes Carey to discuss these issues and more. Also this week, KFF Health News’ Julie Rovner interviews Dan Mendelson, CEO of Morgan Health, a new unit of JPMorgan Chase, about employers’ role in insurance coverage.
KFF Health News' 'What the Health?': Debt Deal Leaves Health Programs (Mostly) Intact
The bipartisan deal to extend the U.S. government’s borrowing authority includes future cuts to federal health agencies, but they are smaller than many expected and do not touch Medicare and Medicaid. Meanwhile, Merck & Co. becomes the first drugmaker to sue Medicare officials over the federal health insurance program’s new authority to negotiate drug prices. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Lauren Weber of The Washington Post, and Jessie Hellmann of CQ Roll Call join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News senior correspondent Sarah Jane Tribble, who reported the latest KFF Health News-NPR “Bill of the Month” feature, about the perils of visiting the U.S. with European health insurance.
A Catch-22 for Clinics: State Bans Limit Abortion Counseling. Federal Title X Rules Require It.
Family planning clinics are getting caught between state abortion bans and a federal requirement to refer patients for abortion care on request.
KFF Health News' 'What the Health?': When an Anti-Vaccine Activist Runs for President
Robert F. Kennedy Jr.’s official entry into the presidential race poses a thorny challenge for journalists: how to cover a candidate who’s opposed to vaccines without amplifying misinformation. And South Carolina becomes the latest state in the South to ban abortion after roughly six weeks of pregnancy. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF Health News senior correspondent Aneri Pattani about her project to track the billions of dollars coming from opioid makers to settle lawsuits.
Abortion Bans Are Driving Off Doctors and Closing Clinics, Putting Basic Health Care at Risk
Doctors say they are reluctant to practice in abortion-banned states, where making the best decision for a patient could run afoul of the law. Even former President Donald Trump’s surgeon general is concerned about the repercussions for women’s health, writes KFF Health News’ chief Washington correspondent, Julie Rovner.
Small, Rural Communities Have Become Abortion Access Battlegrounds
After local leaders in rural Nevada reached an impasse over a proposed Planned Parenthood clinic, an anti-abortion activist pitching local abortion bans across the U.S. arrived at their remote City Hall.
Pequeñas comunidades rurales se han convertido en campos de batalla por el acceso al aborto
La búsqueda por promulgar prohibiciones locales se ha vuelto particularmente crítica en pueblos pequeños, situados en las fronteras entre estados que han restringido el aborto y estados donde las leyes preservan el acceso.
KFF Health News' 'What the Health?': The Abortion Pill Goes Back to Court
A three-judge appeals court panel heard testimony this week about revoking the FDA’s 22-year-old approval of a key pill used in medication abortion and miscarriage management. The judges all have track records of siding with abortion foes. Meanwhile, as the standoff over raising the federal debt ceiling continues in Washington, a major sticking point is whether to impose work requirements on recipients of Medicaid coverage. Victoria Knight of Axios, Rachel Roubein of The Washington Post, and Sandhya Raman of CQ Roll Call join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.
Watch: 5th Circuit Judges Question Two-Decade-Old Approval of Abortion Pill
The 5th Circuit Court of Appeals in New Orleans heard oral arguments Wednesday in a case brought by conservative Christian abortion opponents seeking to revoke FDA approval of mifepristone, a medication used in more than half of abortions in the U.S.
Journalists Give Status Reports on the ‘Personhood’ Debate and the HIV Epidemic
KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
KFF Health News' 'What the Health?': The Crisis Is Officially Ending, but Covid Confusion Lives On
The public health emergency declaration for covid-19 ends May 11, ushering in major changes in how Americans can access and pay for the vaccines, treatments, and tests particular to the culprit coronavirus. But not everyone will experience the same changes, creating a confusing patchwork of coverage — not unlike health coverage for other diseases. Meanwhile, outside advisers to the FDA formally recommended allowing a birth control pill to be sold without a prescription. If the FDA follows the recommendation, it would represent the first over-the-counter form of hormonal contraception. Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Julie Rovner to discuss these issues and more. Plus for “extra credit” the panelists suggest health policy stories they read this week they think you should read, too.
In Idaho, Taking a Minor Out of State for an Abortion Is Now a Crime: ‘Abortion Trafficking’
Under the nation’s first law of its kind, teens must have parental consent to travel for medical care, including in cases of sexual assault or rape. Any adult, including an aunt, grandparent, or sibling, convicted of violating the criminal statute faces up to five years in prison — and could be sued for financial damages.
Montana Passes Significant Health Policy Changes in Controversial Session
The recently ended legislative session was marked by Medicaid reimbursement hikes, abortion restrictions, anti-LGBTQ+ statutes, behavioral health spending, and workforce and insurance measures.
KFF Health News' 'What the Health?': Health Programs Are at Risk as Debt Ceiling Cave-In Looms
A warning from the Treasury Department that the U.S. could default on its debt as soon as June 1 has galvanized lawmakers to intervene. But there is still no obvious way to reconcile Republican demands to slash federal spending with President Joe Biden’s demand to raise the debt ceiling and save the spending fight for a later date. Meanwhile, efforts to pass abortion bans in conservative states are starting to stall as some Republicans rebel against the most severe bans. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Alice Miranda Ollstein of Politico join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.
Colorado Becomes the First State to Ban So-Called Abortion Pill Reversals
The controversial practice of administering progesterone to people after they have taken the abortion pill mifepristone may be coming to an end in Colorado. Pills have emerged as the latest front in the war over abortion since the U.S. Supreme Court overturned Roe v. Wade last summer.
After Idaho’s Strict Abortion Ban, OB-GYNs Stage a Quick Exodus
At least two Idaho hospitals are ending labor and delivery services, with one citing the state’s “legal and political climate” and noting that “recruiting replacements will be extraordinarily difficult” as doctors leave.
KFF Health News' 'What the Health?': Dancing Under the Debt Ceiling
House Republicans passed their plan to raise the nation’s debt ceiling, along with major cuts to health (and other domestic) programs. Unlikely to become law, it calls for new work requirements for adults on Medicaid. Meanwhile, state efforts targeting trans people bear a striking resemblance to the fight against abortion rights. Jessie Hellmann of CQ Roll Call, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Renuka Rayasam, who reported the latest KFF Health News-NPR “Bill of the Month” feature, about a specialist’s demand to be paid as much as $15,000 before treating a woman’s serious pregnancy complication.
Listen: Mifepristone Remains Available for Now. What Happens Next?
The Supreme Court on April 21 ruled that the abortion pill mifepristone should remain widely available while the lower courts consider the issue, blocking earlier rulings that banned or restricted access to the drug. KFF Health News’ Julie Rovner joined NPR’s “Weekend All Things Considered” to discuss the complicated case.
